A detailed history of Sante Capital Fund, LP transactions in Amgen Inc stock. As of the latest transaction made, Sante Capital Fund, LP holds 10,440 shares of AMGN stock, worth $2.92 Million. This represents 4.81% of its overall portfolio holdings.

Number of Shares
10,440
Holding current value
$2.92 Million
% of portfolio
4.81%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $2.34 Million - $2.64 Million
10,440 New
10,440 $2.35 Million
Q2 2022

Jul 27, 2022

SELL
$230.71 - $256.74 $2.97 Million - $3.31 Million
-12,894 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $2.83 Million - $3.13 Million
12,894 New
12,894 $3.12 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sante Capital Fund, LP Portfolio

Follow Sante Capital Fund, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sante Capital Fund, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sante Capital Fund, LP with notifications on news.